The abstract is read at the publisher; the summary is JClub's.
In iPSC-derived spinal muscular atrophy co-cultures, combining SMN1 gene therapy with forskolin increases astrocyte filopodia density and improves motor neuron synapse formation and function.
- Why it matters: Early central afferent synapse dysfunction in spinal muscular atrophy remains mechanistically unclear, limiting targeted therapies for motor neuron synaptic failure.
- What they did: Using healthy and SMA iPSC-derived astrocyte monocultures and PAP-synaptic interface co-cultures, the study applied cell surface capture mass spectrometry, confocal/super-resolution imaging, synaptogliosome isolation, and electrophysiology, then tested SMN1 plus forskolin to stimulate actin dynamics via cyclic adenosine monophosphate.
- The result: SMA astrocytes showed intrinsic actin-associated defects (including reduced pERM proteins), and dual treatment restored branching/filopodia density and improved synapse number and function in SMA motor neurons.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.